| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681876 | Clinical Neurology and Neurosurgery | 2018 | 5 Pages |
Abstract
More than 50% of patients with hemangiopericytoma received postoperative radiation but there was no survival benefit associated with this treatment. This is a hypothesis-generating study and further studies are necessary to better determine how best to treat this rare disease.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Anna Lee, Baho Sidiqi, Arthur Wang, Joseph Safdieh, David Schreiber,